Tiapride

[email protected]
Tiapride
Trade Name
Orphan Indication Tourette syndrome
USA Market Approval USA
USA Designation Date 1998-04-21 00:00:00
Sponsor Sanofi-Synthelabo, Inc.;9 Great Valley Parkway, PO Box 3026;Malvern, Pennsylvania, 19355
Related Access Program
DEKK-TEC, Inc. – Document Safety for DM-CHOC-PEN in AYA Subjects With Advanced Cancer Eastern Regional Medical Center – Oncology Patients With Gastroparesis DEKK-TEC, Inc. – Document Safety for DM-CHOC-PEN in Pediatric and Adolescent Subjects With Advanced Cancer